Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

77.61 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Illumina Insider Sold $1.2M In Company Stock
Alexander Aravanis, SVP And Chief Technology Officer at Illumina (NASDAQ:ILMN), made a large insider sell on October 12, according to a new SEC filing. What Happened: A Form 4... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Illumina Launches New Employee Resource Group iLatinx During Hispanic Heritage Month
SOURCE: Illumina 
Via 3BL Media
Illumina Recognized As #20 on Fortune's Change the World List
SOURCE: Illumina 
Via 3BL Media
Cancer Profiling Market Worth $13.9 Billion by 2025 – Key Players are Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories, Inc. (US)
Via AB Newswire
"Pharmacogenomics Saved My Life"
SOURCE: Illumina 
Via 3BL Media
Topics Product Recall
Exposures Legal Product Safety
Global Nuclease Market: What Are the Key Trends in Market? with Top Companies Like: MercK, Illumina, Thermo Fisher Scientific
The global Nuclease market is extensively evaluated by seasoned research analysts to help readers to expand their market knowledge and become aware of future market changes ahead of time. 
Via SBWire
Topics Initial Public Offering
Exposures Securities Market
Illumina Celebrates International Equal Pay Day
SOURCE: Illumina 
Via 3BL Media
Why Shares of Ilumina Slumped 11.3% in September
The company's merger with GRAIL concerned investors. 
Via The Motley Fool
SBTi Validates and Approves Illumina's Climate Action Targets
SOURCE: Illumina 
Via 3BL Media
Topics Emissions
San Diego Squared Announces 2021 STEM Educators Awards Recipients
SOURCE: Illumina 
Via 3BL Media
Illumina's Sustainability Efforts Rewarded With Gold Rating From EcoVadis
SOURCE: Illumina 
Via 3BL Media
Bioinformatics Market Worth $21.8 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The global bioinformatics market is projected to reach $21.8 billion by 2026. Bioinformatics platforms market report provides crucial industry insights that will help your business grow. 
Via SBWire
Exposures COVID-19
Illumina Ventures Closes $325 Million Fund Supporting Start-ups in Healthcare Innovation
SOURCE: Illumina 
Via 3BL Media
Microfluidics Market Worth $58.8 Billion by 2026 - Exclusive Report by MarketsandMarkets™
Microfluidics Market categorizes the global market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics),... 
Via SBWire
Exposures COVID-19
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
Some trends will persist for decades. 
Via The Motley Fool
Illumina's Spotlight on Ovarian Cancer: Understanding Tumors Through Comprehensive Genomic Profiling
SOURCE: Illumina 
Via 3BL Media
On World Cancer Research Day, Illumina Highlights the Transformative Power of Genomics
SOURCE: Illumina 
Via 3BL Media
Topics Artificial Intelligence Death
Exposures Artificial Intelligence Death
Cancer Diagnostics Market Worth $26.6 Billion by 2026 – Growing Focus on Personalized Medicine and Leading Key Players
The global cancer diagnostics market size is projected to reach USD 26.6 billion by 2026 from USD 17.2 billion in 2021, at a CAGR of 11.5% during the forecast period 
Via SBWire
For the Fourth Consecutive Year, Illumina Was Recognized As a Platinum Tier SANDAG iCommute Diamond Award Winner
SOURCE: Illumina 
Via 3BL Media
Topics Emissions
Illumina Begins Climate Week by Highlighting How Sequencing Supports Resilient Responses to Climate Change
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change Death
Exposures Climate Death
Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle
SOURCE: Illumina 
Via 3BL Media
Next-generation Sequencing (NGS) Market worth $24.2 billion by 2026 | Key Players are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US)
Via AB Newswire
UK's NHS Launches World's Largest Trial Of Blood Test For 50 Types
Britain's National Health Service (NHS) will begin the world's largest trial of Grail Inc's flagship Galleri blood test that can be used to detect... 
Via Benzinga
Single-Cell Analysis Market Worth $6.3 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The global single-cell analysis market is projected to reach $6.3 billion by 2026. Single cell data analysis market report provides crucial industry insights that will help your business grow. 
Via SBWire
Illumina Named #1 for Workers in Its Industry by JUST Capital
SOURCE: Illumina 
Via 3BL Media
Genomics Market worth $54.4 billion by 2025 | Key Players are Illumina, Inc. (US),Thermo Fisher Scientific (US) QIAGEN N.V. (Netherlands)
Via AB Newswire
Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change Emissions
Exposures Climate
Illumina, Inc. (NASDAQ:ILMN) Investor Alert: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 09/08/2021 -- Illumina, Inc is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay
Illumina Inc (NASDAQ: ILMN) and Merck & Co Inc (NYSE: MRK) provided more details on their partnership to develop and commercialize tests that gauge... 
Via Benzinga
Why Illumina Wants Grail Back So Badly
The gene-sequencing giant sees a huge opportunity in diagnostics. 
Via The Motley Fool
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.